Shots: The two P-III studies include Paradigm5 & 6. Paradigm5 involves assessing of Refixia (40 IU/kg, qw) in 25 children with hemophilia B aged ≤12 yrs. resulted in low bleeding […]readmore
Tags : nonacog beta pegol